Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-201-8 | CAS number: 68213-23-0 1 - 2.5 moles ethoxylated
Endpoint summary
Administrative data
Description of key information
Oral (OECD 401), rat: LD50 > 5050 mg/kg bw
Dermal (OECD 402), rat and rabbit: LD50 > 2000 mg/kg bw
Inhalation (OECD 403), rat, 4 h, (limit test): LC50 > 1600mg/m³ (maximum technically attainable concentration)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 050 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 1 600 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
To cover the endpoint acute toxicity of substance C12-18AE (CAS 68213-23-0), studies from similar substances were taken for a weight-of-evidence approach. Read-across is justified because the length of the alkyl chain does not exert any meaningful influence on acute toxicity, whereas the degree of ethoxylation is of more importance. Up to the level of EO = 4, which includes all read-across substances, the toxicity is low (HERA, 2009). The
acute toxicity of alcohol ethoxylates (AEs) has been extensively evaluated in numerous studies with rats and rabbits.The oral LD50 values, tested with the Cas-No. 112-59-4, 71060-57-6, 68002-97-1, 68439-50-9, 68551-12-2, 66455-14-9, 68131-39-5, 68439-49-6, 68920-66-1, 9005-00-9, 9004-98-2 and 70955-07-6, were all at least above 2 g/kg. The test materials were typically solutions administered orally through gavage. The majority of studies conformed to OECD guidelines and/or EC method and were in compliance with GLP regulation.
The same result was achieved for the dermal route when tested with 112-59-4, 71060-57-6, 68002-97-1, 66455-14-9 and 68131-39-5. Exemplary robust study summaries are provided for the oral and the dermal route of exposure. For details on the available data please refer to the category justification.
The acute inhalation studies conducted with a 112-59-4 and 68002-97-1 resulted in a LC50 above 1.6 g/m3.
In summary, no classification is warranted for either route of acute toxicity.
Justification for selection of acute toxicity – oral endpoint
No study chosen due to woe approach.
Justification for selection of acute toxicity – inhalation endpoint
Study with the maximum achievable dose was selected.
Justification for selection of acute toxicity – dermal endpoint
No study chosen due to woe approach.
Justification for classification or non-classification
Classifcation criteria according to 67/548/EEC and (EC)1272/2008 are not fulfilled.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
